These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31118574)

  • 1. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
    Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Ji Z; Zhang R; Lu W; Ma G; Qu Y
    Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
    Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
    Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
    Wu M; Huang Z; Xie H; Zhou Z
    PLoS One; 2013; 8(10):e78231. PubMed ID: 24167609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Geng N; Ren L; Xu L; Zou D; Pang W
    BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
    Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
    Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis.
    Zhou J; Xu J; Cheng A; Li P; Chen B; Sun S
    J Int Med Res; 2020 Nov; 48(11):300060520967856. PubMed ID: 33249959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
    Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
    J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.
    Li W; He W; Zhou Y; Guo Y
    PLoS One; 2020; 15(7):e0234655. PubMed ID: 32614851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
    Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
    Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Feng C; Liu Y; Wang L; Niu D; Han B
    Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
    Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
    Zhao XT; Zhang CF; Liu QJ
    BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
    Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
    Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial.
    Choe JC; Oh JH; Lee HC; Lee JW; Park TS; Park JH; Kim E; Kim MS; Ahn J; Park JS; Lee HW; Choi JH; Cha KS
    Acta Cardiol; 2023 Oct; 78(8):880-888. PubMed ID: 36942830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.